Literature DB >> 17072589

The psychostimulant and rewarding effects of cocaine in histidine decarboxylase knockout mice do not support the hypothesis of an inhibitory function of histamine on reward.

Christian Brabant1, Etienne Quertemont, Christelle Anaclet, Jian-Sheng Lin, Hiroshi Ohtsu, Ezio Tirelli.   

Abstract

RATIONALE AND
OBJECTIVES: Lesion studies have shown that the tuberomammillary nucleus (TM) exerts inhibitory effects on the brain reward system. To determine whether histamine from the TM is involved in that reward inhibitory function, we assessed the stimulant and rewarding effects of cocaine in knockout mice lacking histidine decarboxylase (HDC KO mice), the histamine-synthesizing enzyme. If histamine actually plays an inhibitory role in reward, then it would be expected that mice lacking histamine would be more sensitive to the behavioral effects of cocaine.
MATERIALS AND METHODS: The first experiment characterized spontaneous locomotion and cocaine-induced hyperactivity (0, 8, and 16 mg/kg, i.p.) in wild-type and HDC KO mice. The rewarding effects of cocaine were investigated in a second experiment with the place-conditioning technique.
RESULTS: The first experiment demonstrated that histidine decarboxylase mice showed reduced exploratory behaviors but normal habituation to the test chambers. After habituation to the test chambers, HDC KO mice were slightly, but significantly, less stimulated by cocaine than control mice. This finding was replicated in the second experiment, when cocaine-induced activity was monitored with the place-conditioning apparatus. Furthermore, a significant place preference was present in both genotypes for 8 and 16 mg/kg cocaine, but not for 2 and 4 mg/kg.
CONCLUSIONS: Our data confirm previous results demonstrating that HDC KO mice show reduced exploratory behaviors. However, contrary to the hypothesis that histamine plays an inhibitory role in reward, histamine-deficient mice were not more responsive to the psychostimulant effects of cocaine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072589     DOI: 10.1007/s00213-006-0603-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  47 in total

1.  Dopaminergic effects of histamine administration in the nucleus accumbens and the impact of H1-receptor blockade.

Authors:  R Galosi; L Lenard; A Knoche; H Haas; J P Huston; R K Schwarting
Journal:  Neuropharmacology       Date:  2001-03       Impact factor: 5.250

2.  Comparison of the effects of eleven histamine H1-receptor antagonists on monoamine turnover in the mouse brain.

Authors:  R Oishi; S Shishido; M Yamori; K Saeki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-02       Impact factor: 3.000

3.  The tuberomammillary nucleus region as a reinforcement inhibiting substrate: facilitation of ipsihypothalamic self-stimulation by unilateral ibotenic acid lesions.

Authors:  U Wagner; P Segura-Torres; T Weiler; J P Huston
Journal:  Brain Res       Date:  1993-06-11       Impact factor: 3.252

4.  Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice.

Authors:  Yasuhiko Kubota; Chihiro Ito; Eiichi Sakurai; Eiko Sakurai; Takehiko Watanabe; Hiroshi Ohtsu
Journal:  J Neurochem       Date:  2002-11       Impact factor: 5.372

5.  Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.

Authors:  Gerard B Fox; Timothy A Esbenshade; Jia Bao Pan; Richard J Radek; Kathleen M Krueger; Betty B Yao; Kaitlin E Browman; Michael J Buckley; Michael E Ballard; Victoria A Komater; Holly Miner; Min Zhang; Ramin Faghih; Lynne E Rueter; R Scott Bitner; Karla U Drescher; Jill Wetter; Kennan Marsh; Martine Lemaire; Roger D Porsolt; Youssef L Bennani; James P Sullivan; Marlon D Cowart; Michael W Decker; Arthur A Hancock
Journal:  J Pharmacol Exp Ther       Date:  2004-12-17       Impact factor: 4.030

6.  Histamine-induced arousal in the conscious and pentobarbital-pretreated rat.

Authors:  P W Kalivas
Journal:  J Pharmacol Exp Ther       Date:  1982-07       Impact factor: 4.030

7.  Inhibition of neuronal dopamine uptake by some antiallergic drugs.

Authors:  K Matsunaga; T Sato; H Shuto; Y Tsuruta; K Suemaru; Y Gomita; R Oishi
Journal:  Eur J Pharmacol       Date:  1998-06-05       Impact factor: 4.432

8.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.

Authors:  A Nagy; J Rossant; R Nagy; W Abramow-Newerly; J C Roder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

Review 9.  Studying the neurobiology of stimulant and alcohol abuse and dependence in genetically manipulated mice.

Authors:  D N Stephens; A N Mead; T L Ripley
Journal:  Behav Pharmacol       Date:  2002-09       Impact factor: 2.293

10.  Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse.

Authors:  J Clapham; G J Kilpatrick
Journal:  Eur J Pharmacol       Date:  1994-07-01       Impact factor: 4.432

View more
  12 in total

1.  Prenatal exposure to cocaine alters the development of conditioned place-preference to cocaine in adult mice.

Authors:  C J Malanga; Martina Pejchal; Barry E Kosofsky
Journal:  Pharmacol Biochem Behav       Date:  2007-06-21       Impact factor: 3.533

2.  Spontaneous locomotor activity correlates with the degranulation of mast cells in the meninges rather than in the thalamus: disruptive effect of cocaine.

Authors:  Alice A Larson; Mark J Thomas; Alex McElhose; Katalin J Kovács
Journal:  Brain Res       Date:  2011-04-28       Impact factor: 3.252

3.  L-Dopa activates histaminergic neurons.

Authors:  Yevgenij Yanovsky; Sha Li; Boris P Klyuch; Qiaoling Yao; Patrizio Blandina; M Beatrice Passani; Jian-Sheng Lin; Helmut L Haas; Olga A Sergeeva
Journal:  J Physiol       Date:  2011-01-17       Impact factor: 5.182

4.  Histamine Excites Rat GABAergic Ventral Pallidum Neurons via Co-activation of H1 and H2 Receptors.

Authors:  Miao-Jin Ji; Xiao-Yang Zhang; Xiao-Chun Peng; Yang-Xun Zhang; Zi Chen; Lei Yu; Jian-Jun Wang; Jing-Ning Zhu
Journal:  Neurosci Bull       Date:  2018-08-25       Impact factor: 5.203

5.  Histamine is required for H₃ receptor-mediated alcohol reward inhibition, but not for alcohol consumption or stimulation.

Authors:  J Vanhanen; S Nuutinen; M Lintunen; T Mäki; J Rämö; K Karlstedt; P Panula
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

6.  Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil.

Authors:  M Uguen; D Perrin; S Belliard; X Ligneau; P M Beardsley; J M Lecomte; J C Schwartz
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

7.  Effects of the H3 receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions.

Authors:  Christian Brabant; Livia Alleva; Thierry Grisar; Etienne Quertemont; Bernard Lakaye; Hiroshi Ohtsu; Jian-Sheng Lin; Peter Jatlow; Marina R Picciotto; Ezio Tirelli
Journal:  Psychopharmacology (Berl)       Date:  2008-10-09       Impact factor: 4.530

8.  Histamine and H3 receptor-dependent mechanisms regulate ethanol stimulation and conditioned place preference in mice.

Authors:  Saara Nuutinen; Kaj Karlstedt; Teemu Aitta-Aho; Esa R Korpi; Pertti Panula
Journal:  Psychopharmacology (Berl)       Date:  2009-11-13       Impact factor: 4.530

9.  Effects of L-histidine depletion and L-tyrosine/L-phenylalanine depletion on sensory and motor processes in healthy volunteers.

Authors:  P van Ruitenbeek; A Sambeth; A Vermeeren; S N Young; W J Riedel
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

Review 10.  The histaminergic network in the brain: basic organization and role in disease.

Authors:  Pertti Panula; Saara Nuutinen
Journal:  Nat Rev Neurosci       Date:  2013-07       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.